Cancer

08 September 2016

Overweight people with kidney cancer seem to live longer

A new study found that in patients with advanced kidney cancer, those who were obese or overweight survived considerably longer than those of normal weight.

0

Obesity is a risk factor for kidney cancer. Yet, obese people with advanced kidney cancer seem to live longer than normal-weight or underweight patients, a new study finds.

No difference in tumours

In one database of nearly 2,000 patients with advanced kidney cancer, those who were obese or overweight survived nearly 26 months, compared to 17 months for those of normal weight. And, overweight patients were 16 percent less likely to die during the study period, the researchers reported.

Similar findings were uncovered using three other databases. The records of more than 7,000 kidney cancer patients were reviewed by the study authors.

Read: Kidney problems and diet

"Paradoxically, when overweight individuals developed kidney cancer, especially in its advanced, metastatic form, their disease progressed more slowly and they lived longer than their normal-weight counterparts," said lead researcher Dr Toni Choueiri.

Choueiri is director of the Lank Centre for Genitourinary Oncology at the Dana-Farber Cancer Institute in Boston.

Choueiri's team could not find any differences in the tumours' DNA, such as gene mutations, that might account for the finding. But they did find that a difference in the rate at which genetic information was used by the cells to make proteins in a gene – called fatty acid synthase (FASN) – was decreased in obese patients, compared with normal-weight patients.

A way to prolong survival?

FASN is an essential protein for making fatty acids. High levels of FASN have been found in many types of cancer and are associated with poor outcomes, including in kidney cancer, Choueiri said.

Read: Kidney cancer

The decreased amount of FASN in obese and overweight kidney cancer patients might explain the better outcomes of these patients, he suggested.

Why these people produce less FASN isn't known, Choueiri said. But finding ways to inhibit FASN might be a way to prolong survival in normal-weight patients, he noted.

Drugs that inhibit FASN have been in development for several years and may be a promising approach to cancer treatment, Choueiri added.

"We plan to test FASN inhibitors in an animal model as a possible therapy for kidney cancer," he said.

A range of reasons

The study findings were published online in the Journal of Clinical Oncology.

Dr Joseph Vassalotti is chief medical officer at the National Kidney Foundation. He said, "We know that obesity and overweight is associated with kidney disease."

Read: More bad news: braaied or fried meat ups your kidney cancer risk

But a range of reasons have been proposed for the new study's findings, according to Vassalotti. Among them: reverse causality, where it appears that overweight patients are doing better, but "the real phenomenon is that people who are underweight are doing worse," he said.

It's also possible that an alteration in fatty acid production is the reason, he said.

"This study might lead to other investigations that could yield new therapies for kidney cancer that target fatty acid metabolism," Vassalotti said.

The findings aren't a license to put on weight. "That would definitely be the one thing we would not want to recommend," Vassalotti said.

Read more:

Symptoms of cancer

Treating cancer

Preventing cancer

Copyright © 2016 HealthDay. All rights reserved.

 

Ask the Expert

Cancer expert

CANSA’s purpose is to lead the fight against cancer in South Africa. Its mission is to be the preferred non-profit organisation that enables research, educates the public and provides support to all people affected by cancer. Questions are answered by CANSA’s Head of Health Professor Michael Herbst and Head of Advocacy Magdalene Seguin. For more information, visit cansa.org.za.

Still have a question?

Get free advice from our panel of experts

The information provided does not constitute a diagnosis of your condition. You should consult a medical practitioner or other appropriate health care professional for a physical exmanication, diagnosis and formal advice. Health24 and the expert accept no responsibility or liability for any damage or personal harm you may suffer resulting from making use of this content.

* You must accept our condition

Forum Rules